SMURF2 and metastatic neoplasm: Our analyses revealed that in contrast to normal and carcinoma in situ tissue samples, where SMURF2 exhibited a predominantly nuclear localization, in invasive and metastatic tumors SMURF2 was mostly sequestered in the cytoplasmic compartment of BRCA cells (Figure 4a,b).